Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Targeted next-generation sequencing for the molecular diagnosis of patients with chronic myeloid leukemia with resistance or intolerance to tyrosine kinase inhibitor].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi - 14 Oct 2020

Wu W E, Zhou X, Xu N, Huang J X, Liu L, Tan Y X, Luo J, Qin J Y, Yin C X, Zhou L L, Liu X L

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Neoplasm
Share to High-Throughput Nucleotide Sequencing
Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Protein Kinase Inhibitors

Source

Open in PubMed Open full text

Identifiers

PMID: 33190443
DOI: 10.3760/cma.j.issn.0253-2727.2020.10.010
PMCID: PMC7656074

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Targeted next-generation sequencing for the molecular diagnosis of patients with chronic myeloid leukemia with resistance or intolerance to tyrosine kinase inhibitor].PMID 33190443Read ↗

[High throughput sequencing for detection of 82 kinds of hematologic malignancy related gene mutations in patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors].Semantic proximity Read ↗

[Genome sequencing for personalized cancer treatment].Semantic proximity Read ↗

[Somatic mutation and novel strategies for personalized targeting therapy].Semantic proximity Read ↗

[Molecular monitoring: an essential component of the treatment for chronic myeloid leukemia].Semantic proximity Read ↗

[Cancer genome analysis through next-generation sequencing].Semantic proximity Read ↗

A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of casesSemantic proximity Read ↗

Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors.Semantic proximity Read ↗

Mutation analysis of BCR-ABL1 kinase domain in chronic myeloid leukemia patients with tyrosine kinase inhibitors resistance: a Malaysian cohort study.Semantic proximity Read ↗

Comprehensive analysis of tyrosine kinase domain mutations and imatinib resistance in chronic myeloid leukemia patientsSemantic proximity Read ↗

[Clinical characteristics and prognostic implications of RAS mutations in newly diagnosed acute myeloid leukemia with normal karyotype based on next-generation sequencing analysis].Semantic proximity Read ↗

Somatic mutations identified at diagnosis by exome sequencing can predict response to imatinib in chronic phase chronic myeloid leukemia (CML) patients.Semantic proximity Read ↗

Molecular diagnostics of acute myeloid leukemia: it's a (next) generational thing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.